HCM
PRAH

HMS Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

HMS Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,200
Closed -$689K – 174
2019
Q4 		$689K Sell
6,200
-5,400
-47% -$555K 0.29% 82
2019
Q3 		$1.21M Buy
11,600
+5,400
+87% +$536K 0.45% 62
2019
Q2 		$615K Sell
6,200
-900
-13% -$85.9K 0.27% 94
2019
Q1 		$783K Sell
7,100
-3,700
-34% -$387K 0.33% 82
2018
Q4 		$1.09M Buy
10,800
+5,400
+100% +$546K 0.55% 57
2018
Q3 		$595K Buy
5,400
+1,200
+29% +$125K 0.3% 100
2018
Q2 		$392K Buy
4,200
+400
+11% +$34.4K 0.22% 128
2018
Q1 		$316K Buy
3,800
+1,200
+46% +$107K 0.21% 125
2017
Q4 		$237K Buy
+2,600
New +$216K 0.18% 119

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

HMS Capital Management's PRAH Position: Q1 2020 in Review

HMS Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 7,000 shares — an estimated $778K sold.

HMS Capital Management first reported a position in PRAH in Q4 2017 and held it in 9 quarters. The position peaked at $3.11M in Q3 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • HMS Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • HMS Capital Management sold 7,000 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $778K.
  • HMS Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 9 quarters.
  • HMS Capital Management's PRA Health Sciences, Inc. position peaked at $3.11M in Q3 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on HMS Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.